Accession Number: | 0000899243-21-026817 |
Date: | 2021-06-29 |
Issuer: | VINCERX PHARMA, INC. (VINC) |
Original Submission Date: |
SEELENBERGER ALEXANDER A.
260 SHERIDAN AVENUE, SUITE 400
PALO ALTO, CA 94306
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-29 | P | 7,950 | a | $12.61 | 7,950 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents a weighted average purchase price. actual purchase prices ranged from $12.56 to $12.69 per share. reporting person undertakes to provide upon request by the securities and exchange commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated. |